回复138楼::
1,https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(21)00150-2/fulltext
Lancet 算论文不?75,919,840 Brazilian vaccinees,人数够不够?
对死亡有效性:中国Sinovac是73.7% AZ是92.3%
2,https://www.medrxiv.org/content/10.1101/2021.10.28.21265635v1.full
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong
One month after the second dose of vaccine, BNT162b2 elicited significantly higher PRNT50, PRNT90, sVNT, spike receptor binding, spike N terminal domain binding, spike S2 domain binding, spike FcR binding and antibody avidity levels than CoronaVac.
香港论文,比较mRNA和CoronaVac,也就是Sinovac,结论有效性差很远
3,https://www.medrxiv.org/content/10.1101/2021.08.27.21262721v1
这是泰国科学家拿中国疫苗和阿斯利康相比,得出的结论
Overall, 185 HCWs with a median (IQR) age of 40.5(30.3-55.8) years (94 HCWs in the SV group and 91 in the AZ group) were included. At 4 weeks after completing the SV vaccination, 60.6% (95%CI:50.0-70.6%) had seroconversion evaluated by sVNT(≥68%inhibition), comparable to the patients recovered from mild COVID-19 infection(69.0%), with a rapid reduction to 12.2%(95%CI:6.3-20.8) at 12 weeks. In contrast, 85.7%(95%CI:76.8-92.2%) HCWs who completed the second dose of the AZ for 4 weeks had seroconversion, comparable to the COVID-19 pneumonia patients(92.5%). When using the anti-SAR-CoV-2 total antibody level(≥132 U/ml) criteria, only 71.3% HCWs in the SV group had seroconversion, compared to 100% in the AZ group.
还不如阿什利康
4,https://news.yale.edu/2022/01/20/vaccine-used-much-world-no-match-omicron-variant
耶鲁大学校报,比较Dominican Republic数据,得出结论:who had received two Sinovac shots and a booster had antibody levels that were only about the same as those who’d received two shots of the mRNA vaccines but no booster shot.
Sinovac三针相当于mRNA两针
5,https://www.nature.com/articles/s41591-022-01705-6
打了两针中国疫苗之后, 血清里中和Omicron抗体探测不到.需要打第三针mRNA
neutralization of Omicr